Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CN Stock MarketDetailed Quotes
Zhejiang Orient Gene Biotech (688298)
- 24.90
- -0.33-1.31%
Market Closed Jan 16 15:00 CST
5.02BMarket Cap-10.47P/E (TTM)
25.43High24.70Low2.24MlotVolume25.35Open25.23Prev Close55.92MTurnover1.11%Turnover RatioLossP/E (Static)201.60MShares36.0052wk High0.79P/B5.02BFloat Cap21.1452wk Low30.28Limit Up201.60MShs Float239.67Historical High20.18Limit Down2.89%Range %21.14Historical Low--Dividend TTM24.92Avg Price1.15MlotAsk--Div Yield TTM1Lot Size967.44KlotBid
Zhejiang Orient Gene Biotech (688298) Balance Sheet
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -15.08%2.43B | -17.81%2.5B | -24.76%2.6B | -26.01%3.08B | -41.33%2.86B | -44.64%3.04B | -45.02%3.46B | -36.87%4.16B | -31.11%4.88B | -22.92%5.5B |
| Transactional financial assets | -74.91%211.69M | -65.12%316.73M | -68.30%328.9M | -80.27%207.58M | -1.36%843.81M | 6.41%908.17M | 9.65%1.04B | -9.34%1.05B | 397.25%855.4M | 312.25%853.47M |
| Notes receivable and accounts receivable | -16.93%226.66M | -29.19%193.39M | -13.84%192.37M | 10.80%230.17M | 10.54%272.86M | -0.77%273.1M | -40.80%223.27M | -32.85%207.74M | -56.49%246.84M | -76.91%275.23M |
| -Notes receivable | -47.38%949.61K | 37.59%1.85M | -33.44%1.28M | 32.50%2.08M | --1.8M | --1.34M | --1.92M | --1.57M | ---- | ---- |
| -Accounts receivable | -16.73%225.71M | -29.52%191.54M | -13.67%191.1M | 10.63%228.08M | 9.81%271.05M | -1.26%271.75M | -41.31%221.35M | -33.36%206.16M | -56.49%246.84M | -76.91%275.23M |
| Other receivables (including interest and dividends) | -48.72%10.44M | -53.91%10.86M | -43.35%17.01M | -7.66%19.12M | -74.93%20.37M | -74.00%23.55M | -70.57%30.03M | -71.69%20.7M | -15.37%81.23M | -6.84%90.6M |
| -Other receivable | ---- | -53.91%10.86M | ---- | -7.66%19.12M | ---- | -74.00%23.55M | ---- | -71.69%20.7M | ---- | -6.84%90.6M |
| Advance payment | -12.06%33.27M | -11.81%36.06M | -20.63%32.14M | -0.56%28.45M | -22.89%37.84M | -11.54%40.89M | -50.25%40.49M | -54.52%28.61M | -38.46%49.07M | -61.17%46.23M |
| Inventories | -22.28%332.05M | -26.56%313.05M | -22.86%296.95M | -10.90%308.96M | -0.53%427.26M | 2.88%426.26M | 3.34%384.97M | -19.71%346.78M | -64.36%429.54M | -67.92%414.32M |
| Other current assets | 26.04%120.69M | 28.62%116.5M | 20.28%111.74M | 36.60%103M | -40.32%95.75M | -38.42%90.57M | -14.04%92.9M | -32.99%75.4M | 12.04%160.45M | 110.29%147.08M |
| Total current assets | -26.20%3.37B | -27.43%3.49B | -32.01%3.58B | -32.52%3.98B | -31.95%4.56B | -34.38%4.81B | -36.37%5.27B | -32.59%5.9B | -28.29%6.7B | -27.55%7.32B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -1.77%30.18M | -2.42%30.12M | -4.19%29.7M | -4.07%29.85M | 6.45%30.73M | 5.30%30.87M | 7.84%31M | 113.86%31.11M | 31.51%28.87M | 32.07%29.31M |
| Investment real estate | ---- | ---- | ---- | ---- | --19.73M | --19.88M | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | 1.08%1.51B | ---- | 9.41%1.54B | ---- | 64.75%1.5B | ---- | 109.67%1.41B | ---- | 73.17%908.1M |
| Constru in process | ---- | 40.11%1.24B | ---- | 42.44%1.13B | ---- | 66.25%886.47M | ---- | 115.27%796.48M | ---- | 46.55%533.22M |
| Intangible assets | 30.46%930.15M | -11.12%651.72M | 39.23%670.75M | 44.30%690.91M | 39.64%712.95M | 39.39%733.3M | -8.50%481.75M | -0.50%478.81M | 17.39%510.56M | 33.36%526.07M |
| Goodwill | ---- | ---- | ---- | ---- | --55.37M | --55.37M | --45.63M | ---- | ---- | ---- |
| Long deferred expense | -22.07%47.88M | -22.35%50.59M | -6.38%54.53M | -2.19%59.71M | 40.71%61.44M | 38.86%65.15M | 26.38%58.24M | 68.07%61.05M | 137.64%43.67M | 165.13%46.92M |
| Deferred tax assets | 16.68%272.74M | 18.15%268.6M | 19.51%271.73M | 23.00%268.47M | 31.32%233.75M | 23.56%227.34M | 21.55%227.36M | 12.95%218.26M | 183.15%178M | 76.22%183.99M |
| Usufruct assets | -48.47%37.1M | -44.75%40.62M | -24.13%60.39M | 15.80%65.09M | 195.38%72M | 130.69%73.52M | 144.25%79.6M | 72.93%56.21M | -24.29%24.38M | -13.65%31.87M |
| Other non current assets | -34.72%15.43M | 926.71%308.2M | 2.19%307.35M | 990.28%305.85M | -78.94%23.64M | -72.26%30.02M | 199.59%300.75M | -79.32%28.05M | 132.44%112.27M | -17.92%108.21M |
| Total non current assets | 12.74%4.14B | 13.35%4.12B | 19.70%4.18B | 32.78%4.12B | 48.86%3.67B | 52.32%3.64B | 54.49%3.49B | 58.45%3.1B | 43.27%2.47B | 45.75%2.39B |
| Total assets | -8.82%7.51B | -9.86%7.61B | -11.42%7.76B | -10.02%8.09B | -10.20%8.23B | -13.06%8.44B | -16.91%8.76B | -15.96%9B | -17.16%9.17B | -17.33%9.71B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -44.70%103.26M | -10.04%167.96M | 0.42%177.52M | -41.09%116.78M | -7.10%186.74M | -6.64%186.71M | -11.61%176.77M | --198.22M | --201M | --200M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15.83M | ---- | ---- |
| Notes payable and accounts payable | 26.05%479.04M | 15.30%452.98M | 32.13%480.75M | -14.15%515.49M | -20.59%380.04M | -54.93%392.87M | -70.47%363.84M | -62.00%600.49M | -65.06%478.6M | -51.00%871.78M |
| -Notes payable | 20.94%3.63M | ---- | ---- | ---- | -97.51%3M | -99.06%4.2M | -97.80%13.54M | -95.03%25.76M | -60.59%120.55M | 595.56%446.02M |
| -Accounts payable | 26.09%475.41M | 16.55%452.98M | 37.24%480.75M | -10.31%515.49M | 5.30%377.04M | -8.71%388.67M | -43.18%350.3M | -45.88%574.73M | -66.35%358.05M | -75.17%425.76M |
| Contract liabilities | -0.91%33.25M | -7.38%32.14M | 5.31%35.77M | -10.88%30.99M | 9.54%33.56M | -0.66%34.7M | -70.79%33.97M | -89.75%34.77M | -5.29%30.63M | 6.86%34.93M |
| Advance receipts | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | 3.04%41.97M | -3.54%35.91M | 3.93%35.66M | -0.01%61.15M | 27.20%40.73M | 23.15%37.23M | 5.33%34.31M | -61.03%61.16M | -18.86%32.02M | -48.16%30.23M |
| Taxs payable | 67.74%6.2M | 132.72%5.95M | 180.03%9.7M | 28.63%14.9M | -16.84%3.7M | -73.50%2.56M | -94.18%3.46M | -86.61%11.58M | -95.36%4.45M | -98.52%9.65M |
| Other payable (including interest and dividends) | -25.78%106.52M | -27.38%114.52M | -26.37%115.33M | 43.65%138.39M | 51.74%143.52M | 52.82%157.7M | -15.69%156.64M | 29.79%96.34M | 82.91%94.58M | -25.94%103.19M |
| -Other payable | ---- | -27.38%114.52M | ---- | 43.65%138.39M | ---- | 52.82%157.7M | ---- | 29.79%96.34M | ---- | -25.94%103.19M |
| Non current liabilities due within one year | -95.34%15.11M | -95.47%16.88M | -91.78%30.79M | 390.98%324.82M | 6,839.85%324.2M | 6,531.69%373.13M | 10,010.00%374.44M | 1,763.00%66.16M | -33.15%4.67M | -7.56%5.63M |
| Other current liabilities | -17.62%1.23M | -28.59%1.2M | -36.79%1.2M | 3.69%1.29M | -21.16%1.49M | -0.48%1.68M | 438.93%1.9M | -96.73%1.25M | 260.05%1.89M | 8.11%1.69M |
| Total current liabilities | -29.39%786.58M | -30.26%827.57M | -22.58%886.73M | 10.87%1.2B | 31.39%1.11B | -5.61%1.19B | -37.42%1.15B | -52.35%1.09B | -46.91%847.85M | -52.94%1.26B |
| Current liabilities | ||||||||||
| Long term account payable | ---- | --7.97M | ---- | --7.49M | ---- | ---- | ---- | ---- | ---- | --0 |
| Specific account payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.51%4.66M |
| Estimate liabilities | 1.87%6.02M | 8.70%6.19M | 210.78%17.62M | 206.71%17.47M | --5.91M | --5.7M | 67.26%5.67M | 68.02%5.7M | ---- | ---- |
| Deferred tax liabilities | 83.21%54.07K | 65.81%109.54K | --0 | 545.85%232.67K | -98.93%29.51K | -97.60%66.06K | ---- | -98.70%36.02K | --2.75M | --2.75M |
| Long term deferred income | 160.37%26.32M | 157.14%26.54M | 154.10%26.77M | 151.05%26.98M | -29.71%10.11M | -29.03%10.32M | -25.00%10.54M | -24.14%10.75M | 0.37%14.38M | 0.37%14.55M |
| Lease liabilities | -45.56%28.94M | -43.59%30.18M | -33.61%40.5M | 7.31%47.17M | 121.92%53.16M | 111.58%53.5M | 118.37%61M | 53.45%43.96M | -2.19%23.95M | -11.98%25.29M |
| Total non current liabilities | 229.93%228.33M | 166.03%185.13M | 169.01%207.7M | -72.44%99.35M | -82.48%69.21M | -82.48%69.59M | -82.70%77.21M | 252.45%360.44M | 332.19%395.09M | 767.03%397.25M |
| Total liabilities | -14.22%1.01B | -19.38%1.01B | -10.48%1.09B | -9.89%1.3B | -4.81%1.18B | -24.07%1.26B | -46.30%1.22B | -39.25%1.45B | -26.38%1.24B | -39.12%1.65B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%201.6M | 0.00%201.6M | 0.00%201.6M | 0.00%201.6M | 0.00%201.6M | 0.00%201.6M | 20.00%201.6M | 20.00%201.6M | 20.00%201.6M | 20.00%201.6M |
| Capital reserve funds | 0.38%397.89M | 0.53%397.89M | 0.53%397.89M | 0.62%397.89M | -1.68%396.39M | -1.84%395.77M | -9.25%395.77M | -9.37%395.42M | -20.15%403.18M | -19.56%403.18M |
| Surplus reserve funds | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | 40.00%84M | 40.00%84M |
| Retained profit | -7.43%5.97B | -8.24%6.02B | -8.68%6.07B | -7.88%6.18B | -8.35%6.45B | -8.17%6.56B | -10.15%6.65B | -9.85%6.71B | -16.72%7.04B | -12.23%7.15B |
| Less:Treasury stock | 18.05%326.94M | 0.71%276.95M | --276.95M | --276.95M | --276.95M | --275M | ---- | --0 | ---- | ---- |
| Other composite income | 33.41%33.11M | -26.40%33.08M | 38.39%47.08M | 29.57%54.9M | -53.30%24.82M | -21.41%44.94M | 126.71%34.02M | 49.91%42.37M | -5.85%53.15M | 315.61%57.19M |
| Shareholders equity without minority interests | -7.55%6.36B | -7.87%6.46B | -11.40%6.52B | -10.64%6.65B | -11.56%6.88B | -11.13%7.01B | -9.12%7.36B | -8.90%7.44B | -15.80%7.78B | -11.17%7.89B |
| Minority interests | -22.65%132.14M | -21.00%137.76M | -18.85%142.91M | 28.76%146.34M | 16.02%170.84M | 5.01%174.39M | 6.01%176.11M | -29.03%113.66M | 4.51%147.25M | 13.91%166.07M |
| Total shareholder equity | -7.92%6.49B | -8.19%6.6B | -11.57%6.66B | -10.04%6.79B | -11.05%7.05B | -10.80%7.19B | -8.81%7.54B | -9.29%7.55B | -15.50%7.93B | -10.77%8.06B |
| Total liabilityies and equity | -8.82%7.51B | -9.86%7.61B | -11.42%7.76B | -10.02%8.09B | -10.20%8.23B | -13.06%8.44B | -16.91%8.76B | -15.96%9B | -17.16%9.17B | -17.33%9.71B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"